Tonyali, O. Et Al. 2013. Efficacy and toxicity of Trastuzumab and Paclitaxel plus Capecitabine in the first-line treatment of HER2-positive metastatic breast cancer. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.139, no.6 , 981-986.

Tonyali, O., Benekli, M., Berk, V., Coskun, U., ÖZKAN, M., Yildiz, R., ... Ucgul, E.(2013). Efficacy and toxicity of Trastuzumab and Paclitaxel plus Capecitabine in the first-line treatment of HER2-positive metastatic breast cancer. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.139, no.6, 981-986.

Tonyali, Onder Et Al. "Efficacy and toxicity of Trastuzumab and Paclitaxel plus Capecitabine in the first-line treatment of HER2-positive metastatic breast cancer," JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.139, no.6, 981-986, 2013

Tonyali, Onder Et Al. "Efficacy and toxicity of Trastuzumab and Paclitaxel plus Capecitabine in the first-line treatment of HER2-positive metastatic breast cancer." JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.139, no.6, pp.981-986, 2013

Tonyali, O. Et Al. (2013) . "Efficacy and toxicity of Trastuzumab and Paclitaxel plus Capecitabine in the first-line treatment of HER2-positive metastatic breast cancer." JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.139, no.6, pp.981-986.

@article{article, author={Onder Tonyali Et Al. }, title={Efficacy and toxicity of Trastuzumab and Paclitaxel plus Capecitabine in the first-line treatment of HER2-positive metastatic breast cancer}, journal={JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY}, year=2013, pages={981-986} }